Position in PFE
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$245,856
-$43,648 QoQ
Shares Held
10,210
-1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#2,281
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST FINANCIAL CORP /IN/ holds $10,663,305 across 12 Drug Manufacturers - General names. PFE ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,212 | $5,051,998 | |
| 2 | ABBV |
AbbVie Inc.
|
9,288 | $2,337,231 | |
| 3 | MRK |
Merck & Co., Inc.
|
11,730 | $1,507,305 | |
| 4 | JNJ |
Johnson & Johnson
|
2,095 | $532,067 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,635 | $497,548 | |
| 6 | NVO |
Novo Nordisk A S
|
6,470 | $310,171 | |
| 7 | PFE |
Pfizer Inc
This page
|
10,210 | $245,856 | |
| 8 | NVS |
Novartis AG
|
599 | $93,875 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,856 | 10,210 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $289,504 | 10,310 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $254,229 | 10,210 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $260,150 | 10,210 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $270,978 | 11,179 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $319,968 | 12,627 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $359,533 | 13,552 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $408,632 | 14,120 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $353,946 | 12,650 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $372,820 | 13,435 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $446,503 | 15,509 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $514,996 | 15,526 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $575,141 | 15,680 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $656,063 | 16,080 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $847,867 | 16,547 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $771,488 | 17,630 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $798,508 | 15,230 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $790,941 | 15,278 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $903,818 | 15,306 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $867,855 | 20,178 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $803,875 | 20,528 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $704,418 | 19,443 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $851,525 | 23,133 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $894,597 | 24,376 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $765,540 | 23,411 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $798,993 | 24,479 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||